Managing and coordinating research on C. difficile
Official title: Oklahoma C. difficile U19 Administrative Core
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10892820 · Data updated 2026-11-12
This study is all about improving teamwork among researchers working on C. difficile, so they can share ideas, keep track of their progress, and help develop better treatments and vaccines for this infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | July 25, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $82,111 |
| NIH project number | 5U19AI174994-02 |
| Project ID | NIH-10892820 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by C. difficile infections or those at high risk for such infections.
✕Less likely to help
Patients who are not affected by C. difficile or do not have risk factors for infection may not receive direct benefits from this research.
What this research studies
This research focuses on the administrative management of the Oklahoma C. difficile U19 program, which aims to enhance collaboration among various research projects related to C. difficile. The Administrative Core will oversee communication between investigators, organize meetings, and ensure that progress reports are collected and documented. Additionally, it will coordinate outreach activities and maintain fiscal management to support the overall success of the program. By fostering collaboration and effective management, the program aims to advance research on C. difficile and its vaccine.
Why it matters
Potential benefit: If successful, this research could lead to improved coordination and effectiveness of C. difficile research, potentially accelerating the development of better treatment options and vaccines.
How similar studies have gone: While this research focuses on administrative management, similar collaborative approaches in other research areas have shown success in enhancing research outcomes.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Lang, Mark L — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Lang, Mark L
Related research
Other NIH-funded projects on the same topics.
-
Primary care research network in Oklahoma to boost rural patient trials
A nationwide NIH-supported effort to strengthen Oklahoma’s primary care research network so doctors can run big clinical trials and real‑world studies in rural communities.
-
N-myristoylation and DNA damage response in Alzheimer’s disease
A study to understand how a protein modification called myristoylation affects the DNA damage response in people who have Alzheimer’s-related conditions.
-
Genetically engineered mouse model to study and treat high-risk pediatric rhabdomyosarcoma
A research project aims to create mouse models that mimic high-risk pediatric rhabdomyosarcoma and test therapies that target the NOTCH1 pathway to slow or stop tumor growth.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Vascular signals from brain blood vessels influence immune-suppressing cells in glioblastoma
This grant explores how blood vessel cells in glioblastoma shape immune cells to help the tumor grow, with the aim of making immunotherapies work better for patients.
-
TFEB as a key switch to keep muscles healthy as we age
A study in aging adults and aging muscle tissues looks at whether boosting TFEB can improve how muscles maintain themselves and recover after disuse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.